This is a firm-fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to the UCLA Department of Pathology & Laboratory Medicine. The contract is for $21,360.00 and has a completion date of February 9, 2025. The purpose is to provide whole exome library preparation services to generate exome sequencing data from clinical samples for the NHLBI's Wiestner Laboratory. The contract...
The National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded a $42,427 firm fixed price delivery order contract to Illumina, Inc. to provide reagents and kits necessary for next-generation sequencing on laboratory instruments in support of NHLBI-funded investigators. The place of performance is Illumina's facilities in San Diego, California. The period of performance is one month,...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency under the National Institutes of Health (NIH), awarded a $31,567.82 firm fixed price delivery order contract to Illumina, Inc., a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. The contract is for DNA library preparation kits to support next-generation DNA sequencing and library preparation for the NHLBI's DNA Sequencing Core to assist investigators. This contract does...
The National Heart, Lung and Blood Institute of the National Institutes of Health, Department of Health and Human Services, awarded a $35,041.80 firm fixed price delivery order to Illumina, Inc. to provide Illumina kits and reagents in support of next-generation sequencing activities on Illumina instruments for Institute-funded investigators. The sequencing core facility at the NHLBI requires the products from Illumina to carry out its mission of performing next-generation sequencing on Illumina...
The National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health under the Department of Health and Human Services, has awarded a firm fixed price delivery order valued at $15,569.68 to Illumina, Inc. to provide reagents and kits for its sequencing core facility. The core facility supports investigators by carrying out next-generation sequencing on laboratory instruments, and requires the reagents and kits to conduct this work. The contract has a period of...
The National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health under the Department of Health and Human Services, has awarded a firm fixed price delivery order valued at $24,397.74 to Illumina, Inc. to provide reagents and kits for its sequencing core facility. The core facility supports investigators by carrying out next-generation sequencing on laboratory instruments, and requires the reagents and kits to conduct this work. The contract has a period of...
The National Heart, Lung and Blood Institute (NHLBI) awarded a $70,299.26 firm fixed price delivery order to Illumina, Inc. to provide next-generation sequencing kits and reagents. The kits and reagents will support the Institute's Sequencing Core Facility in carrying out sequencing on Illumina instruments for investigators. Funding comes from the Department of Health and Human Services National Institutes of Health. Illumina will perform under the contract through September 29, 2023 with all...
The National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health within the Department of Health and Human Services, awarded a firm fixed price delivery order valued at $41,507.66 to Illumina, Inc. of San Diego, California. The purpose of this order is to provide reagent kits that are required by the NHLBI Sequencing Core Facility to carry out next-generation sequencing in support of Institute-funded investigators. Work will be performed in San Diego through...
The National Heart, Lung and Blood Institute (NHLBI) awarded a $91,319.73 firm fixed price delivery order to Illumina, Inc. to provide Illumina kits and reagents for the Institute's Sequencing Core Facility. The Core Facility supports investigators conducting next-generation sequencing on Illumina instruments and requires the products to carry out those services. Funding comes from the National Institutes of Health (NIH), an agency of the Department of Health and Human Services (HHS). The...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a firm fixed-price delivery order worth $18,145.37 to Illumina, Inc. for DNA sequencing library preparation kits. This order is part of a broader Indefinite Delivery Contract between Illumina and the Department of the Navy Bureau of Medicine and Surgery, valued up to $3.3 million, to support nucleic acid sequencing needs at the Naval Medical Research Center. The contract...